Blue Trust’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-776
Closed -$11.3K – 2573
2026
Q2
$11.3K Sell
776
-24,014
-97% -$317K ﹤0.01% 1833
2026
Q1
$342K Buy
24,790
+1,325
+6% +$20K ﹤0.01% 607
2025
Q4
$423K Buy
23,465
+344
+1% +$6.18K ﹤0.01% 543
2025
Q3
$428K Buy
23,121
+898
+4% +$14.1K ﹤0.01% 538
2025
Q2
$356K Buy
22,223
+1,497
+7% +$26.7K ﹤0.01% 571
2025
Q1
$403K Sell
20,726
-500
-2% -$10.5K 0.01% 470
2024
Q4
$468K Buy
+21,226
New +$409K 0.01% 396

Other funds holding CLBT

Blue Trust's CLBT Position: Q3 2026 in Review

Blue Trust sold out of Cellebrite (CLBT) in Q3 2026, closing a stake of 776 shares — an estimated $11.3K sold.

Blue Trust first reported a position in CLBT in Q4 2024 and held it in 7 quarters. The position peaked at $468K in Q4 2024. 135 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Blue Trust reported no remaining Cellebrite position as of Q3 2026 after selling out during the quarter.
  • Blue Trust sold 776 Cellebrite shares in Q3 2026, an estimated $11.3K.
  • Blue Trust first reported a position in Cellebrite in Q4 2024 and held it in 7 quarters.
  • Blue Trust's Cellebrite position peaked at $468K in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.